First Trust Advisors LP Buys 7,439 Shares of HealthEquity, Inc. $HQY

First Trust Advisors LP boosted its stake in HealthEquity, Inc. (NASDAQ:HQY) by 24.3% in the first quarter, HoldingsChannel reports. The firm owned 38,086 shares of the company’s stock after buying an additional 7,439 shares during the period. First Trust Advisors LP’s holdings in HealthEquity were worth $3,183,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of HQY. William Blair Investment Management LLC acquired a new position in shares of HealthEquity during the fourth quarter valued at about $169,956,000. Norges Bank acquired a new stake in shares of HealthEquity in the 4th quarter valued at about $66,927,000. AQR Capital Management LLC grew its stake in shares of HealthEquity by 148.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock valued at $116,016,000 after buying an additional 661,795 shares during the period. Wasatch Advisors LP grew its stake in shares of HealthEquity by 9.3% in the 1st quarter. Wasatch Advisors LP now owns 7,202,934 shares of the company’s stock valued at $601,949,000 after buying an additional 613,288 shares during the period. Finally, Millennium Management LLC increased its position in HealthEquity by 151.5% in the 4th quarter. Millennium Management LLC now owns 951,563 shares of the company’s stock valued at $87,173,000 after buying an additional 573,283 shares in the last quarter. 99.55% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on HQY shares. Citigroup reiterated a “market outperform” rating on shares of HealthEquity in a report on Monday, June 1st. Wall Street Zen upgraded HealthEquity from a “hold” rating to a “buy” rating in a report on Saturday, July 25th. Wells Fargo & Company set a $111.00 target price on HealthEquity in a research report on Monday, June 1st. Citizens Jmp increased their target price on HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a report on Monday, June 1st. Finally, KeyCorp reissued an “overweight” rating on shares of HealthEquity in a research report on Tuesday, May 26th. Eleven research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, HealthEquity has a consensus rating of “Moderate Buy” and an average price target of $110.93.

HealthEquity Trading Down 0.9%

HQY opened at $103.44 on Friday. HealthEquity, Inc. has a fifty-two week low of $72.76 and a fifty-two week high of $106.42. The firm has a market capitalization of $8.65 billion, a PE ratio of 38.74, a P/E/G ratio of 1.76 and a beta of 0.21. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44. The company’s 50-day moving average is $93.03 and its 200 day moving average is $85.66.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. The business had revenue of $354.64 million during the quarter, compared to the consensus estimate of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The company’s revenue for the quarter was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. As a group, research analysts predict that HealthEquity, Inc. will post 3.92 earnings per share for the current fiscal year.

Insider Activity at HealthEquity

In related news, EVP Delano Ladd sold 7,500 shares of the stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $675,000.00. Following the completion of the sale, the executive vice president directly owned 91,141 shares of the company’s stock, valued at approximately $8,202,690. This represents a 7.60% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 3,142 shares of the firm’s stock in a transaction on Friday, May 29th. The shares were sold at an average price of $95.00, for a total value of $298,490.00. Following the transaction, the executive vice president owned 59,113 shares in the company, valued at approximately $5,615,735. This trade represents a 5.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 17,905 shares of company stock valued at $1,651,280 over the last 90 days. Insiders own 1.60% of the company’s stock.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.